Drug Delivery Solutions

AlbuMiz - a versatile nano-sized drug delivery system based on albumin.  The system offers multiple drug delivery solutions.

The Technology

The nano-albumin (nab) technology has been successfully applied for the delivery of a range of small molecule anti-cancer drugs, most notably paclitaxel (abraxane). Here we developed a technology based on albumin that also allows the delivery of other drugs such as metal-based drugs, proteins and genes (oligonucleotides, siRNA). The drug carrier has a shell made from albumin and a core made from polymer. The core is tailored specifically to the type of drug

Key Benefits

  • Can be tailored to suit most delivery needs 
  • Size of nanoparticle can be altered between 50-150 nm, probably smaller and larger particles can be generated
  • Albumin shell mimics the current nab-technology
  • Albumin is the main substituent of blood, the drug carrier is compatible and degradable


  • Drug delivery of various drugs including proteins, small drugs, genes, peptides and metal-based drugs
  • Main application: Delivery of anti-cancer drugs and anti-arthritis drugs.

The Opportunity

UNSW is seeking a commercial partner to licence and/or to work collaboratively with the inventor Professor Martina Stenzel in the development of this potentially disruptive drug delivery technology.



Please click here to view a one-page Technology Brief


Patent Information:
For Information, Contact:
Joe Brennan
Business Development Manager
NewSouth Innovations Pty Ltd
Reference ID: 12_2686
Martina Stenzel
Wei Scarano
Mingtao (roger) Liang
Domenic Svejkar
Drug Development
Life Sciences
Metabolic Diseases
Oncology Diseases
© 2023. All Rights Reserved. Powered by Inteum